Loading
A phase 3 trial of Bicalutamide, Goserelin / leuprolide, Docetaxel, Estramustine and Aspirin in Prostate cancer, run by UNICANCER, completed.
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse is a phase 3 interventional study registered as NCT00055731 by UNICANCER, with 413 participants recorded, started 2002-11-14 and reaching its primary completion in 2010-12-21. Interventions recorded: bicalutamide, Goserelin Acetate, docetaxel, Estramustine phosphate sodium, acetylsalicylic acid, conventional surgery, radiation therapy. Conditions recorded: Prostate Cancer.
Linked to the drug Estramustine because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
Shares Estramustine, Bicalutamide, Prostate cancer and the tag pipeline.
Shares Estramustine, Docetaxel, Prostate cancer and the tag pipeline.
Shares Bicalutamide, Goserelin / leuprolide (ovarian function suppression), Prostate cancer and the tag pipeline.
Shares Bicalutamide, Goserelin / leuprolide (ovarian function suppression), Prostate cancer and the tag pipeline.
Shares Bicalutamide, Goserelin / leuprolide (ovarian function suppression), Docetaxel, Prostate cancer and the tag pipeline.
Shares Bicalutamide, Goserelin / leuprolide (ovarian function suppression), Prostate cancer and the tag pipeline.
Shares Bicalutamide, Goserelin / leuprolide (ovarian function suppression), Prostate cancer and the tag pipeline.
Shares Aspirin, Prostate cancer and the tag pipeline.